Evidence map›Paper›PMID 38654044›Full record

ArticleScientific reports2024

Genomic landscape of diploid and aneuploid microsatellite stable early onset colorectal cancer.

Yumei Zhou, Xianfeng Chen, Jun Chen, Conner D Kendrick, Ramesh K Ramanathan, Rondell P Graham, Kimberlee F Kossick, Lisa A Boardman, Michael T Barrett

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yumei ZhouDepartment of Research, Mayo Clinic in Arizona, Scottsdale, AZ, USA.
Xianfeng ChenDivision of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, 55905, USA.
Jun ChenDivision of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, 55905, USA.
Conner D KendrickDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 55905, USA.
Ramesh K RamanathanMayo Clinic Cancer Center, Phoenix, AZ, 85054, USA.
Rondell P GrahamAnatomic Pathology, Mayo Clinic, Rochester, MN, 55905, USA.
Kimberlee F KossickDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 55905, USA.
Lisa A BoardmanDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 55905, USA.
Michael T BarrettDepartment of Research, Mayo Clinic in Arizona, Scottsdale, AZ, USA. barrett.michael@mayo.edu.
Mayo Clinic in Arizona · USMayo Clinic in Florida · USWinnMed · USMayo Clinic Hospital · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Lila J. Rutten · 1985 to 2026
$151.3M
HRD-IA signatures in pancreatic ductal adenocarcinomaUH3CA238926 · NCI · MAYO CLINIC ARIZONA · PI BORAD, MITESH · 2022 to 2024
$966k
NCI NIH HHS 5P30 CA15083-36NCI NIH HHS P30 CA015083NCI NIH HHS UH3 CA238926NCI NIH HHS UH3CA238926
6 · The paper itself

Abstract

Although colorectal cancer (CRC) remains the second leading cause of cancer-related death in the United States, the overall incidence and mortality from the disease have declined in recent decades. In contrast, there has been a steady increase in the incidence of CRC in individuals under 50 years of age. Hereditary syndromes contribute disproportionately to early onset CRC (EOCRC). These include microsatellite instability high (MSI+) tumors arising in patients with Lynch Syndrome. However, most EOCRCs are not associated with familial syndromes or MSI+ genotypes. Comprehensive genomic profiling has provided the basis of improved more personalized treatments for older CRC patients. However, less is known about the basis of sporadic EOCRC. To define the genomic landscape of EOCRC we used DNA content flow sorting to isolate diploid and aneuploid tumor fractions from 21 non-hereditary cases. We then generated whole exome mutational profiles for each case and whole genome copy number, telomere length, and EGFR immunohistochemistry (IHC) analyses on subsets of samples. These results discriminate the molecular features of diploid and aneuploid EOCRC and provide a basis for larger population-based studies and the development of effective strategies to monitor and treat this emerging disease.

Indexed as

AneuploidyColorectal NeoplasmsDiploidyMicrosatellite InstabilityAdultAge of OnsetErbB ReceptorsFemaleGenomicsHumansMaleMiddle AgedMutationEGFR protein, humanErbB ReceptorsAneuploid tumorsDiploid tumorsEarly onset colorectal cancerMutational signatures

Identifiers

PMID38654044
PMCPMC11039710
OpenAlexW4395029999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.